News
Important Only
AES Corp - Argentina Ordered To Pay AES $733 Mln In Damages - SEC Filing
June 2 (Reuters) - AES Corp AES.N:AES CORP - ARGENTINA ORDERED TO PAY AES $733 MILLION IN DAMAGES - SEC FILINGAES CORP - ICSID TRIBUNAL ISSUES ARBITRATION AWARD IN AES'S FAVOR - SEC FILINGSource text: [ID:n0000950103-25-006759]Reuters
Mon, Jun 2
Regeneron Expands Clinical-Stage Obesity Portfolio
June 2 (Reuters) - Regeneron Pharmaceuticals Inc REGN.O:REGENERON EXPANDS CLINICAL-STAGE OBESITY PORTFOLIO WITH STRATEGIC IN-LICENSING OF NOVEL DUAL GLP-1/GIP RECEPTOR AGONISTREGENERON PHARMACEUTICALS INC - TO PAY $80 MILLION UPFRONT TO HANSOHREGENERON PHARMACEUTICALS INC: POTENTIAL ADDITIONAL PAYME...Reuters
Mon, Jun 2
Chime Financial - IPO Price Estimated Between $24 And $26 Per Share - SEC Filing
June 2 (Reuters) - Chime Financial Inc CHYM.O:CHIME FINANCIAL INC - IPO PRICE ESTIMATED BETWEEN $24 AND $26 PER SHARE - SEC FILINGCHIME FINANCIAL NOW SEES IPO OF 32 MILLION SHARES OF CLASS A COMMON STOCK- SEC FILINGCHIME FINANCIAL- CEO CHRISTOPHER BRITT TO HOLD 34.7% VOTING POWER, POST OFFERING - SE...Reuters
Mon, Jun 2
Teck Provides Update On Chile Operations Maintenance
June 2 (Reuters) - Teck Resources Ltd TECKb.TO:TECK PROVIDES UPDATE ON CHILE OPERATIONS MAINTENANCETECK RESOURCES LTD - ANNOUNCES MAINTENANCE SHUTDOWN AT CARMEN DE ANDACOLLO OPERATIONSTECK RESOURCES LTD - PRODUCTION INTERRUPTED FOR ABOUT ONE MONTH FOR REPAIRSTECK RESOURCES LTD - NO MATERIAL PRODUCTI...Reuters
Mon, Jun 2
C&K Group - U.S. IPO Price Expected Between $4.00 And $5.00 Per Share - SEC Filing
June 2 (Reuters) - C&K GROUP LTD - U.S. IPO PRICE EXPECTED BETWEEN $4.00 AND $5.00 PER SHARE - SEC FILINGC&K GROUP LTD - FILES FOR IPO OF 1.5 MILLION CLASS A SHARES - SEC FILINGC&K GROUP LTD: REVERE SECURITIES LLC IS UNDERWRITER TO U.S. IPO- SEC FILINGSource text: [ID:n0001213900-25-0496...Reuters
Mon, Jun 2
Brazil Potash Corp - Offer & Sale From Time To Time By Selling Shareholder Of Up To 56.1 mln Common Shares Of Co - SEC Filing
June 2 (Reuters) - Brazil Potash Corp GRO.A:BRAZIL POTASH CORP: OFFER & SALE FROM TIME TO TIME BY SELLING SHAREHOLDER OF UP TO 56.1 MILLION COMMON SHARES OF CO - SEC FILINGSource text: [ID:n0001193125-25-132372]Reuters
Mon, Jun 2
Theravance Biopharma Sells Remaining Royalty Interest in Trelegy Ellipta to GSK for $225 Million
June 2 (Reuters) - GSK plc GSK.L:THERAVANCE BIOPHARMA, INC. SELLS REMAINING ROYALTY INTEREST IN TRELEGY ELLIPTA TO GSK FOR $225 MILLIONTHERAVANCE BIOPHARMA INC - FINANCIAL GUIDANCE FOR 2025 REMAINS UNCHANGEDTHERAVANCE BIOPHARMA INC - RETAINS RIGHTS TO UP TO $150 MILLION IN MILESTONES FROM ROYALTY PH...Reuters
Mon, Jun 2
Outlook Therapeutics Announces Commercial Launch Of Lytenava In Germany And UK For Treatment Of Wet AMD
June 2 (Reuters) - Outlook Therapeutics Inc OTLK.O:OUTLOOK THERAPEUTICS® ANNOUNCES COMMERCIAL LAUNCH OF LYTENAVA™ (BEVACIZUMAB GAMMA) IN GERMANY AND THE UK FOR THE TREATMENT OF WET AMDOUTLOOK THERAPEUTICS INC - LYTENAVA APPROVED FOR WET AMD IN EU AND UKReuters
Mon, Jun 2
